CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ γδ T Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Knight, Andrea ^a   Arnouk, Hilal ^b   Britt, William ^b   Gillespie, G Yancey ^b   Cloud, Gretchen A ^b   Harkins, Lualhati ^b   Su, Yun ^b   Lowdell, Mark W ^a   Lamb, Lawrence S ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; ULBP 2 PROTEIN; ULBP 3 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CELL EXPANSION; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; MALE; PRIMARY TUMOR; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL DESTRUCTION; VDELTA1+ T CELL;

CELL LINE; CELL LINE, TUMOR; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GLIOBLASTOMA; GPI-LINKED PROTEINS; HUMANS; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 84881326207     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068729     Document Type: Article

References (53)

1. Medewar P, (1948) Immunity to homologous grafted skin III. The fate of skin homografts transplanted to the brain, the subcutaneous tissue, and the anterior chamber of the eye. British Journal of Experimental Pathology 29: 58-69.
2. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R, (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116: 79-86.
3. Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, et al. (2005) Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18: 838-843.
4. Cobbs CS, Soroceanu L, Denham S, Zhang W, Britt WJ, et al. (2007) Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness. J Neurooncol 85: 271-280.
5. Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, et al. (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 10: 10-18.
6. Odeberg J, Wolmer N, Falci S, Westgren M, Sundtrom E, et al. (2007) Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes. J Neurosci Res 85: 583-593.
7. Karman J, Ling C, Sandor M, Fabry Z, (2004) Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol 173: 2353-2361.
8. Karman J, Ling C, Sandor M, Fabry Z, (2004) Dendritic cells in the initiation of immune responses against central nervous system-derived antigens. Immunol Lett 92: 107-115.
9. Smyth MJ, Strobl SL, Young HA, Ortaldo JR, Ochoa AC, (1991) Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol 146: 3289-3297.
10. Inge TH, McCoy KM, Susskind BM, Barrett SK, Zhao G, et al. (1992) Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes. J Immunol 148: 3847-3856.
11. Jachimczak P, Bogdahn U, Schneider J, Behl C, Meixensberger J, et al. (1993) The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J Neurosurg 78: 944-951.
12. De Paoli P, Gennari D, Martelli P, Cavarzerani V, Comoretto R, et al. (1990) Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection. The Journal of infectious diseases 161: 1013-1016.
13. Maccario R, Revello MG, Comoli P, Montagna D, Locatelli F, et al. (1993) HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes. Journal of Immunology 150: 1437-1445.
14. Dechanet J, Merville P, Berge F, Bone-Mane G, Taupin JL, et al. (1999) Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis 179: 1-8.
15. Dechanet J, Merville P, Lim A, Retiere C, Pitard V, et al. (1999) Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 103: 1437-1449.
16. Halary F, Pitard V, Dlubek D, Krzysiek R, de la Salle H, et al. (2005) Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J Exp Med 201: 1567-1578.
17. Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, et al. (2008) Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood 112: 1317-1324.
18. Knight A, Madrigal AJ, Grace S, Sivakumaran J, Kottaridis P, et al. (2010) The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood 116: 2164-2172.
19. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, et al. (1999) Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proceedings of the National Academy of Sciences of the United States of America 96: 6879-6884.
20. Wu J, Groh V, Spies T, (2002) T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells. J Immunol 169: 1236-1240.
21. Poggi A, Venturino C, Catellani S, Clavio M, Miglino M, et al. (2004) Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. Cancer Res 64: 9172-9179.
22. Spada FM, Grant EP, Peters PJ, Sugita M, Melian A, et al. (2000) Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med 191: 937-948.
23. Leslie DS, Vincent MS, Spada FM, Das H, Sugita M, et al. (2002) CD1-mediated gamma/delta T cell maturation of dendritic cells. J Exp Med 196: 1575-1584.
24. Lamb LS Jr, Musk P, Ye Z, van Rhee F, Geier SS, et al. (2001) Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response. Bone Marrow Transplant 27: 601-606.
25. Meeh PF, King M, O'Brien RL, Muga S, Buckhalts P, et al. (2006) Characterization of the gammadelta T cell response to acute leukemia. Cancer immunology, immunotherapy: CII 55: 1072-1080.
26. Schilbach K, Frommer K, Meier S, Handgretinger R, Eyrich M, (2008) Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy. J Immunother 31: 896-905.
27. Maeurer MJ, Martin D, Walter W, Liu K, Zitvogel L, et al. (1996) Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med 183: 1681-1696.
28. Maeurer MJ, Walter W, Martin D, Zitvogel L, Elder E, et al. (1997) Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. Scandinavian Journal of Immunology 45: 182-192.
29. Ferrarini M, Heltai S, Pupa SM, Mernard M, Zocchi R, (1996) Killing of Laminin Receptor-Positive Human Lung Cancers by Tumor-Infiltrating Lymphocytes Bearing gd+ T-Cell Receptors. Journal of the National Cancer Institute 88: 436-441.
30. Lamb LS, Gee AP, Hazlett LJ, Musk P, Parrish RS, et al. (1999) Influence of T cell depletion method on circulating gd+ T cell reconstitution and potential role in the graft-versus-leukemia effect. Cytotherapy 1: 7-19.
31. Godder KT, Henslee-Downey PJ, Mehta J, Park BS, Chiang KY, et al. (2007) Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 39: 751-757.
32. Hayday A, Tigelaar R, (2003) Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3: 233-242.
33. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, et al. (2007) Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 27: 334-348.
34. Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, et al. (2011) Preclinical evaluation of ex vivo expanded/activated gammadelta T cells for immunotherapy of glioblastoma multiforme. J Neurooncol 101: 179-188.
35. Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, et al. (2009) Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma. Neuro Oncol 11: 357-367.
36. Lamb LS Jr, (2009) gammadelta T cells as immune effectors against high-grade gliomas. Immunol Res 45: 85-95.
37. Lopez RD, Xu S, Guo B, Negrin RS, Waller EK, (2000) CD2-mediated IL-12-dependent signals render human gamma-delta T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies. Blood 96: 3827-3837.
38. Ponten J, Macintyre EH, (1968) Long term culture of normal and neoplastic human glia. Acta pathologica et microbiologica Scandinavica 74: 465-486.
39. Clark MJ, Homer N, O'Connor BD, Chen Z, Eskin A, et al. (2010) U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS genetics 6: e1000832.
40. Bady P, Diserens AC, Castella V, Kalt S, Heinimann K, et al. (2012) DNA fingerprinting of glioma cell lines and considerations on similarity measurements. Neuro Oncol 14: 701-711.
41. Cavanaugh VJ, Deng Y, Birkenbach MP, Slater JS, Campbell AE, (2003) Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. Journal of Virology 77: 1703-1717.
42. Janssen O, Wesselborg S, Heckl-Ostreicher B, Pechhold K, Bender A, et al. (1991) T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gamma delta + T cells. Journal of Immunology 146: 35-39.
43. Kabelitz D, Pechhold K, Bender A, Wesselborg S, Wesch D, et al. (1991) Activation and activation-driven death of human gamma/delta T cells. Immunol Rev 120: 71-88.
44. Argentati K, Re F, Serresi S, Tucci MG, Bartozzi B, et al. (2003) Reduced number and impaired function of circulating gamma delta T cells in patients with cutaneous primary melanoma. Journal of Investigative Dermatology 120: 829-834.
45. Schilbach KE, Geiselhart A, Wessels JT, Niethammer D, Handgretinger R, (2000) Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells. J Immunother 23: 536-548.
46. Knight A, Mackinnon S, Lowdell MW, (2012) Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells. Cytotherapy 14: 1110-1118.
47. Groh V, Steinle A, Bauer S, Spies T, (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279: 1737-1740.
48. Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, et al. (2011) Preclinical evaluation of ex vivo expanded/activated gammadelta T cells for immunotherapy of glioblastoma multiforme. Journal of neuro-oncology 101: 179-188.
49. Muntasell A, Magri G, Pende D, Angulo A, Lopez-Botet M, (2010) Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection. Blood 115: 5170-5179.
50. Bennett NJ, Ashiru O, Morgan FJ, Pang Y, Okecha G, et al. (2010) Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus. Journal of Immunology 185: 1093-1102.
51. Rolle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Soderberg-Naucler C, et al. (2003) Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J Immunol 171: 902-908.
52. Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, et al. (2003) Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197: 1427-1439.
53. Luo MH, Fortunato EA, (2007) Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells. J Virol 81: 10424-10436.